Does parenteral support affect liver stiffness in short bowel syndrome?
Part of Digestive system clinical trials.
This study tests whether giving extra nutrition through a vein (parenteral support) affects liver stiffness in people with short bowel syndrome. It uses a special ultrasound test called FibroScan to measure liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older) with short bowel syndrome.
- You currently receive parenteral nutrition or fluids at least 4 days per week and at least 10 liters per week.
- Your medical condition is stable.
- You do not have known liver cirrhosis (scarring of the liver).
- You do not have an active infection, severe dehydration, or electrolyte problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, non-invasive way to measure liver stiffness using a device called FibroScan. It aims to make liver checkups easier and more comfortable for people with liver disease.
This study uses a special ultrasound technique called elastography to measure how stiff the liver is in children with cholestatic liver disease. The goal is to see how well this test can detect liver scarring (fibrosis) compared to a liver biopsy.
This study tests a new treatment called FT1 for people with short bowel syndrome. It aims to help you absorb more nutrients and fluids from food, potentially reducing the need for IV nutrition.
This study uses an ultrasound probe during a routine endoscopy to measure liver stiffness, which can help detect liver scarring (fibrosis) in people with fatty liver disease (MASLD). If you are already scheduled for an endoscopy and have no signs of advanced liver scarring, you may be able to join.
This trial uses a simple ultrasound test (measuring liver and spleen stiffness) to predict if a patient with cirrhosis and advanced liver cancer has enlarged veins in the esophagus. The goal is to avoid unnecessary invasive procedures like endoscopy.
This study tests a new way to measure liver scarring using a non-invasive ultrasound of the spleen (spleen stiffness measurement). It's for people with fatty liver disease (MASLD) who have advanced fibrosis (scarring) to see if this method can accurately detect the severity of liver damage.
Hear when a new Short Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.